|Articles|March 20, 2008

DigiFab production increased to combat temporary antibody shortage

Fougera and Protherics announce increased DigiFab production to counteract shortage.

Fougera and Protherics, Inc. have announced an increase in production of their digoxin immune fab (ovine) (

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!

Related Content